• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: imatinib mesylate
Date Designated: 05/06/2014
Orphan Designation: Treatment of progressive multifocal leukencephalopathy
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Inhibikase Therapeutics, Inc.
3350 Riverwood Parkway
Atlanta, Georgia 30339
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-